Globally, spine surgery has remained a strong medtech growth market in the face of a variety of pressures that have hindered growth of other medical technologies. In general, spine technology sales have benefited from the following drivers:
- The ageing population worldwide
- Increasing incidence of obesity
- A growing middle class in developing countries, with the ability to pay out of pocket for spine surgery
- Improving worldwide economy
- Technological device enhancements, leading to improved surgical results
- Developments in minimally invasive spine surgery (MISS) devices driving a strong increase in MISS, with its numerous advantages
- In the US, improvements in reimbursement as clinical trials demonstrate the efficacy of treatments using the devices
- US healthcare reform leading to medical insurance coverage for more people, allowing those suffering from intractable back pain to receive surgical treatment
Overall, the global spine surgery market will see a nearly 7% compound annual growth rate from 2011 to 2020, with select emerging segments demonstrating dramatically higher growth. Below is illustrated the change, from 2011 to 2020, in percentage of total share of the worldwide spine surgery market represented by each technology segment.
Source: MedMarket Diligence Report #M520, "Worldwide Spine Surgery: Products, Technologies, Markets and Opportunities, 2010-2020."
Note, please, that a decline in a share % above does not necessarily reflect a decline in absolute value of sale for that particular segment. In reality, the only segment with an absolute decline in sales from 2012 to 2020 is segment sales of bone morphogenetic proteins (especially for Medtronic's Infuse) which have taken a hit as a result of complication rates ensuing from BMPs.